Recommendations made by the PBAC - August 2019 intracycle meeting

4 October 2019 - The recommendations from the August 2019 PBAC intracycle meeting are now available and have been updated. ...

Read more →

Recommendations made by the PBAC - July 2019

23 August 2019 - The recommendations from the July 2019 PBAC meeting are now available. ...

Read more →

Australia’s deadliest cancer has a new treatment

23 August 2019 - A powerful new combination treatment for Australia’s deadliest cancer has been approved for subsidy in a move ...

Read more →

Public consultation – standardised redactions of Public Summary Documents

2 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) - March 2019 meeting

19 July 2019 - The Public Summary Documents (first time rejections and deferrals) from the March 2019 PBAC meeting are ...

Read more →

PBAC Public Summary Documents - March 2019 meeting

5 July 2019 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2019 PBAC ...

Read more →

Recommendations made by the PBAC - May 2019 intracycle meeting

28 June 2019 - The Department of Health has published an update of the outcomes from the May 2019 PBAC ...

Read more →

Recommendations made by the PBAC - March 2019

31 May 2019 - The recommendations from the March 2019 PBAC meeting have been updated. ...

Read more →

PBAC Public Summary Documents - November 2018 meeting (rejections and deferrals)

15 March 2019 - The Public Summary Documents (first time rejections and deferrals) from the November 2018 PBAC meeting are now ...

Read more →

Direct-acting anti-virals for hepatitis C - outcome statement

8 March 2019 - The outcome statement for the direct-acting anti-virals for hepatitis C stakeholder meeting held on 13 December 2018 ...

Read more →

PBAC public summary documents - November 2018 meeting

1 March 2019 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the November 2018 PBAC ...

Read more →

PBAC - 2018 in review (cancer)

10 January 2019 - The PBAC considered many submissions for new cancer medicines (new medicine, new indication and new combination ...

Read more →

PBAC - 2018 in review

7 January 2019 - The PBAC considered 195 submissions in 2018; 173 were considered by the PBAC in 2017. ...

Read more →

Recommendations made by the PBAC - November 2018

14 December 2018 - The outcomes from the November 2018 PBAC meeting are now available but not in full. ...

Read more →

Novartis' erenumab proving to be a headache for the PBAC

12 November 2018 - Record number of consumer comments; place in clinical therapy unclear. ...

Read more →